(Press-News.org) ROCHESTER, Minn. — While immunosuppressive medications are critical to prevent rejection of transplant organs, they also come with plenty of downsides. They can cause harsh side effects, like headaches and tremors, and increase the risk for infection and cancer. But what if there was a way to prevent organ rejection without using these medications?
That goal fuels the work of Mark Stegall, M.D., a longtime Mayo Clinic transplant researcher. He leads a team of researchers developing pioneering therapies to prevent organ rejection without the need for immunosuppression. A recently published study in the American Journal of Transplantation is offering hope for patients.
Using stem cells to prevent organ rejection
Mayo Clinic participated in the multisite phase 3 clinical trial detailed in the study. The goal was to see whether people who simultaneously received both a kidney and stem cell transplant from a closely matched sibling could discontinue all immunosuppressive medications after a year. The results were promising. The study found that 75% of participants were able to stop taking the medication for more than two years. At Mayo Clinic, three patients participated, with two off immunosuppression medications for over three years and one on a low dose.
"I've been involved in transplant research for more than 30 years, and we've done quite a few amazing things. But in the scheme of things, this research is right at the very top. It's been a goal — to be able to safely get transplant recipients off immunosuppression — for longer than I've been doing this. We're very excited about it," says Dr. Stegall, a co-author of the study.
The research being done across Mayo Clinic is part of a growing trend in transplant to explore ways to use cellular therapies to prevent organ rejection. It is also a cornerstone of Mayo Clinic's Transforming Transplant Initiative, which has the bold goal of ensuring everyone who wants a transplant can get one and to make transplants more successful.
To qualify for the clinical trial, the transplant recipients and donors needed to be siblings whose tissue types closely matched. The donor agreed to donate their stem cells in addition to their kidney to their sibling. The recipient receives the transplant, undergoes radiation and then receives the stem cell transplant. The goal was to wean recipients off immunosuppression medication after a year.
'Almost like the transplant didn't happen'
For Minnesota native Mark Welter, the results have been better than he imagined. Four years ago, he needed a kidney transplant due to polycystic kidney disease, an inherited condition that causes cysts to grow on the kidneys. The Mayo Clinic patient volunteered to be a part of the clinical trial in hopes of not having to worry about immunosuppression medication the rest of his life. His younger sister Cindy Kendall immediately stepped forward to donate a kidney and her stem cells to help her brother.
"Being able to see him get off those medications has been amazing," Cindy says. "He just gets to live his life to the fullest. He has been able to see both of his daughters get married and meet his grandchildren."
Watch: Inteview with Mark Welter, Cindy Kendall and Dr. Mark Stegall
Mark has not taken immunosuppression medication for more than three years.
"I feel fantastic. I actually feel like I did before the transplant, which has been the greatest thing," Mark says. "It's almost like the transplant didn't happen."
There is still plenty of work to be done to advance this research. This clinical trial only involved siblings with closely matching tissue types. Researchers want to know if stem cell transplants can prevent rejection in recipients paired with a less closely matched donor.
"Even in closely matched siblings, immunosuppression is needed lifelong. We have seen stopping medications even at eight to 10 years post-transplant leads to rejection. Our goal is to find ways to reduce or stop immunosuppressive medications after transplant so patients can have longer lasting kidneys with fewer side effects," says Andrew Bentall, M.B., Ch.B., M.D., a Mayo Clinic transplant nephrologist.
Journalists: Press kit, including b-roll, photos and interviews are available here. Clinical trial participants and Mayo researchers are available for interviews. Please contact newsbureau@mayo.edu to schedule.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
END
Eliminating the need for lifelong immunosuppressive medications for transplant patients
2025-07-07
ELSE PRESS RELEASES FROM THIS DATE:
Open problems: Cracking cell complexity with collective intelligence
2025-07-07
Researchers from more than 50 international institutions have launched Open Problems (https://openproblems.bio), a collaborative open-source platform to benchmark, improve, and run competitions for computational methods in single-cell genomics. Co-led by Helmholtz Munich and Yale University, the initiative aims to standardize evaluations, foster reproducibility, and accelerate progress towards open challenges in this fast-moving field.
A Common Language for a Complex Field
Single-cell genomics allows scientists to analyze individual cells at unprecedented resolution, revealing how they function, interact, and contribute to health and disease. But as the field has grown, so has ...
International Gemini Observatory and SOAR discover surprising link between fast X-ray transients and the explosive death of massive stars
2025-07-07
Since their first detection, powerful bursts of X-rays from distant galaxies, known as fast X-ray transients (FXTs), have mystified astronomers. FXTs have historically been elusive events, occurring at vast distances away from Earth and only lasting seconds to hours. Einstein Probe (EP), launched in 2024, is dedicated to observing transient events in the X-ray and is changing the game for astronomers looking to understand the origin of these exotic events.
In January 2025 EP alerted astronomers to the nearest FXT known at the time, named EP 250108a. Its proximity to Earth (2.8 billion light-years away) ...
At the computer for the lecture or in the lecture hall? It depends!
2025-07-07
During the coronavirus pandemic, german universities had to act quickly: Lectures and seminars had to be offered online via Zoom. After the pandemic-related lockdowns, many lecturers introduced synchronous hybrid teaching/learning settings. These are courses in which students can take part either on site in the seminar room or online at the same time.
Students are therefore faced with the decision every session as to whether they want to take part in the course online or on site. Three researchers from the Professorship of Adult Education/Continuing Education at the Institute of Education at Julius-Maximilians-Universität Würzburg (JMU) have investigated the factors ...
A general framework for airfoil flow field reconstruction based on transformer-guided diffusion models
2025-07-07
High-resolution flow field data are essential for accurately evaluating the aerodynamic performance of aircraft. However, acquiring such data via large-scale numerical simulations or wind tunnel experiments is highly resource-intensive. Flow field super-resolution techniques aim to reconstruct high-resolution information from low-resolution data, significantly improving data acquisition efficiency. With the rapid advancement of artificial intelligence, especially deep learning, neural network-based super-resolution methods have been widely adopted for flow field reconstruction. Nonetheless, these ...
A rapidly structured aircraft concept design method based on generative artificial intelligence
2025-07-07
The conceptual design stage is a key step in aircraft development, laying the foundation for performance, efficiency and innovation. Traditionally, this process relies heavily on experienced designers to iterate designs based on design theory, design experience, and engineering calculations, which places high demands on designers' design experience and professional skills. With the continuous improvement of aircraft design requirements and the continuous expansion of application scenarios, it is necessary to explore new conceptual design methods to free designers from a large amount of low-value, highly repetitive, and experience-dependent ...
Breakthrough in artificial blood production
2025-07-07
Scientists have been working on the artificial production of blood for several decades. Now, researchers from the University of Konstanz and Queen Mary University of London have taken an important step closer to that goal with a new discovery.
Roughly 15,000 units of blood are needed daily in Germany, most of which currently come from donations. Research into developing alternative sources, such as large-scale artificial blood production, has been ongoing for decades but is still far from reaching its widespread utility. The main challenge ...
Advancements in vortex particle method enable stable simulation of high Reynolds number flows and shear turbulence
2025-07-07
The Vortex Particle Method (VPM), a meshless vortex flow simulation approach, is gaining traction for its efficient simulation of unsteady vortex wakes evolution that is shed by aircrafts, rotors and wind turbines. It outperforms traditional grid-based CFD methods with faster computation, lower dissipation, and easier satisfaction of the CFL stability condition. However, traditional VPM has huge challenge on accurately simulating these complex flows, due to its poor numerical stability, which is compromised by factors such ...
New insights into divergent nitrogen fixation in subtropical forests
2025-07-07
Nitrogen fixation is a critical ecological process that converts atmospheric nitrogen into bioavailable forms, essential for plant growth and carbon sequestration. This study, published in Forest Ecosystems, focused on two primary forms of biological nitrogen fixation (BNF): symbiotic nitrogen fixation (SNF), which occurs within the root nodules of nitrogen-fixing plants, and asymbiotic nitrogen fixation (ANF), which is carried out by free-living microorganisms in soil and litter. Understanding the environmental controls on these processes is crucial for predicting ...
New bispecific antibody exploits immune receptor proximity to control autoimmunity
2025-07-07
Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune diseases. One key component of these pathways is Lymphocyte Activation Gene 3 (LAG-3)—a classical immunosuppressive receptor that has long posed unresolved questions regarding its biological mechanisms.
In a new study published on June 30 in Cell, researchers from the Institute of Biophysics of the Chinese Academy of Sciences, the Grossman School of Medicine at New York University, and the School of Medicine at Zhejiang University have ...
New precision medicine approach identifies a promising ovarian cancer treatment
2025-07-07
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The research reveals a promising strategy against this hard-to-treat malignancy, and more generally demonstrates a powerful new approach for the identification of effective regimens to treat genetically diverse cancers.
Ovarian cancer is genetically diverse in the sense that it can be driven by mutations in many different genes. This complicates the standard strategy of developing drugs to target common driver mutations. In the study, published July 7 in Cell Reports Medicine, the researchers applied a ...